These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 9815968
1. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Murphy LC, Hilsenbeck SG, Dotzlaw H, Fuqua SA. Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968 [Abstract] [Full Text] [Related]
3. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Dotzlaw H, Miller T, Karvelas J, Murphy LC. Cancer Res; 1990 Jul 15; 50(14):4204-8. PubMed ID: 2364377 [Abstract] [Full Text] [Related]
4. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F, Noguchi S. Cancer; 2000 Oct 15; 89(8):1732-8. PubMed ID: 11042568 [Abstract] [Full Text] [Related]
6. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Zhang QX, Borg A, Fuqua SA. Cancer Res; 1993 Dec 15; 53(24):5882-4. PubMed ID: 8261397 [Abstract] [Full Text] [Related]
7. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Ariazi EA, Clark GM, Mertz JE. Cancer Res; 2002 Nov 15; 62(22):6510-8. PubMed ID: 12438245 [Abstract] [Full Text] [Related]
10. Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Leygue E, Hall RE, Dotzlaw H, Watson PH, Murphy LC. Br J Cancer; 1999 Feb 15; 79(5-6):978-83. PubMed ID: 10070900 [Abstract] [Full Text] [Related]
11. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Bayer T, Keiding N. Cancer Res; 1987 Nov 15; 47(22):6126-33. PubMed ID: 3664512 [Abstract] [Full Text] [Related]
15. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Castles CG, Fuqua SA, Klotz DM, Hill SM. Cancer Res; 1993 Dec 15; 53(24):5934-9. PubMed ID: 8261406 [Abstract] [Full Text] [Related]
17. [Expression of steroid receptors and DNA synthesis in male breast cancer]. Petroni S, Mangia A, D'Amico C, Simone G. Pathologica; 2003 Feb 15; 95(1):31-6. PubMed ID: 12735283 [Abstract] [Full Text] [Related]
18. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis. Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F. Eur J Obstet Gynecol Reprod Biol; 2008 Dec 15; 141(2):147-52. PubMed ID: 18768247 [Abstract] [Full Text] [Related]